1 / 3

Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP<1.0 mg/L (RR=1.0)

Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP<1.0 mg/L (RR=1.0).

celerina-andeana
Download Presentation

Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP<1.0 mg/L (RR=1.0)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP<1.0 mg/L (RR=1.0) *Adjusted for age, smoking status, month of blood sampling, parental CHD history, alcohol intake, exercise activity level, total cholesterol/HDL cholesterol ratio, body mass index, diabetes, and hypertension; and in women only, also adjusted for fasting status at time of blood sampling and postmenopausal hormone therapy status. Pai JK et al. N Engl J Med 2004; 351:2599-2610.

  2. Relative CHD risk by baseline CRP plasma levels, by quintiles relative to lowest quintile (RR=1.0) *Age, smoking status, month of blood sampling; in women only, also adjusted for fasting status at time of blood sampling. **Parental CHD history, alcohol intake, exercise activity level, total cholesterol/HDL cholesterol ratio, body mass index (BMI); in women only, also adjusted for postmenopausal hormone therapy status. Pai JK et al. N Engl J Med 2004; 351:2599-2610.

  3. Relative CHD risk by baseline CRP plasma levels, by quintiles relative to lowest quintile (RR=1.0) *Age, smoking status, month of blood sampling; in women only, also adjusted for fasting status at time of blood sampling. **Parental CHD history, alcohol intake, exercise activity level, total cholesterol/HDL cholesterol ratio, body mass index (BMI); in women only, also adjusted for postmenopausal hormone therapy status. Pai JK et al. N Engl J Med 2004; 351:2599-2610.

More Related